Loss of work productivity due to illness and medical treatment

Journal of Occupational and Environmental Medicine

Volumn 41, Issue 11, 1999, Pages 948-953

  Cockburn, Iain M ^b   Bailit, Howard L ^b   Berndt, Ernst R ^b   Finkelstein, Stan N ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BROMPHENIRAMINE; CARBINOXAMINE; CHLORPHENIRAMINE; CLARITIN D; CLEMASTINE; DIPHENHYDRAMINE; LORATADINE; MEPYRAMINE; PHENIRAMINE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PHENYLTOLOXAMINE; PROMETHAZINE; PSEUDOEPHEDRINE; TERFENADINE;

ARTICLE; DRUG EFFECT; ECONOMIC ASPECT; HUMAN; JOB PERFORMANCE; NOSE ALLERGY; PRODUCTIVITY; SOMNOLENCE; WORK CAPACITY;

ABSENTEEISM; ADOLESCENT; ADULT; AGE FACTORS; EFFICIENCY; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RESPIRATORY HYPERSENSITIVITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SICKNESS IMPACT PROFILE; SLEEP STAGES; UNITED STATES; WORK CAPACITY EVALUATION; WORKPLACE;

EID: 0032742422     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-199911000-00005     Document Type: Article

References (17)

1. Adelsberg BR. Sedation and performance issues in the treatment of allergic conditions. Arch Intern Med 1997;157:494-500.
2. Smith AP, Thomas M, Brockman P, Kent J, Nicholson KG. Effect of influenza B virus infection on human performance. Br Med Jnl. 1993;306:760-61.
3. Carpenter JA. The effect of caffeine and alcohol on simple visual reaction time. Jnl Comp Physiol Psychol. 1959;52:491-96.
4. Blanc PD. Cisternas M, Smith S, Yelin EH. Asthma, employment status, and disability among adults treated by pulmonary and allergy specialists. Chest. 1996; 109:688-96.
5. Keech M, Scott AJ, Ryan PJJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med. 1998;48:85-90.
6. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. PharmacoEconomics. 1992;2(1):67-76.
7. Drummond MF. Cost-of-illness studies. A major headache? PharmacoEconomics 1992;2:1-4.
8. Becker GS. Human capital. A theoretical and empirical analysis, with special reference to education. National Bureau of Economic Research, New York, 1964.
9. Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment vs. clinical information systems Implications for outcomes research Annals Intern Med. 1993;119(8): 844-50.
10. Green J. Utility and limitations of claims data. Annals Intern Med. 1994;12:1050-51.
11. Crown WH, Obenchain RL, Englehart L, Lair T, Buesching DP, Croghan TM. The application of sample selection models to outcomes research. The case of evaluating the effects of antidepressant therapy on resource utilization. Stats in Med 1998;17:1943-58.
12. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the medical outcomes study. Jnl Amer Stat Assn. 1989;262(7):914-19.
13. Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatment of depression and the functional capacity to work. Arch Gen Psychiat. 1992;49:761-68.
14. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4(5):353-65.
15. Berndt ER, Finkelstein SN, Greenberg PE, et al. Workplace performance effects from chronic depression and its treatment. Jnl Health Econ. 1998;5:511-35.
16. Levit KR, Lazenby HC, Braden BR, National Health Accounts Team. National Health Spending Trends in 1996. Health Affairs. 1998:17(1):35-51.
17. McCunney RJ, Anstadt G, Burton WL, Gregg D. The competitive advantage of a healthy work force: opportunities for occupational medicine (editorial). J Occup Environ Med. 1997;39:611-613.